News | February 10, 2026
Time Medical India unveils next-generation MRI platforms at IRIA 2026
The unveiling marks Time Medical India’s entry into next-generation helium-free MRI technology
The unveiling marks Time Medical India’s entry into next-generation helium-free MRI technology
HCG clinicians contributing to one of the largest bodies of oncology research from India
Pfizer’s anti-infectives portfolio includes both established therapies for moderate to severe infections and newer, clinically robust antimicrobial treatments
The therapy is currently completing Phase 1 clinical trials in renal cell carcinoma and non-small cell lung cancer
Leading the showcase is FCT iStream, Fujifilm’s latest CT scanner built on a “Less is More” design philosophy
HYMPAVZI is already approved in the US for patients 12 and older with hemophilia A without factor VIII inhibitors or hemophilia B without factor IX inhibitors
Under the agreement, Apotex’s branded division, Searchlight Pharma, will seek regulatory approval and handle marketing and distribution in Canada
Hologic has been at the forefront of cervical cancer screening for decades
As CRISPR and prime editing applications advance, researchers increasingly rely on longer guide RNAs to boost editing efficiency and reduce off-target effects
NATCO’s Erdafitinib is indicated for the treatment of adult patients with locally advanced unresectable or metastatic urothelial carcinoma harbouring susceptible FGFR3 genetic alteration
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
